🔴 Trulieve Cannabis is trading 3.1% down in pre-market after $271 million revenue miss

Trulieve Cannabis is trading 3.1% down now at $8.72 after second-quarter revenue of $271 million missed estimates.

• Earnings release showed a $406 million GAAP loss, tied largely to the Harvest deconsolidation, plus $0.11 adjusted EPS, 60% gross margin, and $98 million adjusted EBITDA.
• The move follows a 6.64% gain to $9.00 on August 6; the earnings call is scheduled for 8:30 a.m. ET on August 7, 2026.
• The pre-market decline suggests investors are prioritizing revenue softness and restructuring-related uncertainty.